About | Free Trial

Last Update

2015-08-07T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Michele Maio?

Dr. Michele Maio

Chairman

University Hospital of Siena

Direct Phone: +39 **********       

University Hospital of Siena

Background Information

Affiliations

Scientific Advisory Board Member
Sbarro Health Research Organization

Advisory Board Member
Journal of Translational Medicine

Member, Editorial Boards
Seminars

Member
American Association for Cancer Research Inc

Education

M.D. degree summa cum laude

University of Naples

Web References (47 Total References)


VisMederi A Trip through the Sienese Economy: a meeting this Friday on the present and future of Biotechnologies - VisMederi

www.vismederi.com [cached]

Andrea Paolini, General Director of Toscana Life Sciences; Dario Neri, co-founder of Philogen, full Professor of Biomacromolecules at the Department of Chemistry and Applied Sciences at the Swiss Federal Institute of Technology in Zurich, Michele Maio, President of NIBIT and U.O.C director of Oncological Immunotherapy at the University Hospital of Siena and Emanuele Montomoli, CSO VisMederi Ltd and Associate Professor of Hygiene and Preventative Medicine, University of Siena will give talks on the subject.


Michele Maio, ...

miataproject.org [cached]

Michele Maio, University Hospital of Siena, Siena, Italy


S.H.R.O. Institution :: Administration

www.shro.org [cached]

Michele Maio, MD. Ph.D. Director Division of Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy


Global Conference on Developing New Treatments for Melanoma - Munich 2011

www.melanomaglobal2011.org [cached]

Michele Maio, MD Professor of Oncology Department of Oncology University Hospital of Siena Strada delle Scotte n 14 53100, Siena, Italy Phone: +39 577 586336 E-Mail: mmaio@cro.it


Big steps forward for advanced melanoma treatment | AudioMedica.com

www.audiomedica.com [cached]

Dr Michele Maio MD, PhD, Director of Medical Oncology and Immunotherapy at University Hospital, Siena, Italy, reported the doubling of five-year overall survival in patients randomised to receive ipilimumab added to their standard dacarbazine thereapy for advanced melanoma.

Similar Profiles

Other People with this Name

Other people with the name Maio

Dora Maio
BankSA Limited

Andrea Maio
INTERNATIONAL FLAVORS & FRAGRANCES INC

Sharon Di Maio
Eastgate Ltd

Joao Maio Almeida
Sanofi Pasteur Limited

Vincenzo Maio
LinkedIn

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory